Complications in Singleton Pregnancies Following Previous Cesarean Myomectomy
NCT ID: NCT04766567
Last Updated: 2021-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2020-06-15
2021-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Myomectomy During Cesarean Section
NCT03095014
Myomectomy During CS: A Retrospective Cohort Study
NCT03270605
Single or Double-layer Uterine Closure Techniques
NCT03629028
Pregnancy Outcomes Following Myomectomy
NCT06474065
Vaginal Misoprostol Versus Bilateral Uterine Artery Ligation in Decreasing Blood Loss in Trans-abdominal Myomectomy
NCT02643186
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Serosal myomectomy
Patients with singleton pregnancy, who had serosal myomectomy during cesarean section
Cesarean section with cesarean myomectomy (serosal)
Serosal or endometrial myomectomy performed during cesarean section
Endometrial myomectomy
Patients with singleton pregnancy, who had endometrial myomectomy during cesarean section
Cesarean section with cesarean myomectomy (serosal)
Serosal or endometrial myomectomy performed during cesarean section
Control group
Patients with singleton pregnancy, who did not have myomectomy during cesarean section
Cesarean section without myomectomy
Cesarean delivery without performing myoemctomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cesarean section with cesarean myomectomy (serosal)
Serosal or endometrial myomectomy performed during cesarean section
Cesarean section without myomectomy
Cesarean delivery without performing myoemctomy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cesarean section technique should include: Transverse hysterotomy to enter the uterine cavity, single layer closure of the uterine wall, non-sutured visceral and parietal peritoneum
* Myomectomy during cesarean section should include: only patients, who have undergone a single myomectomy and have been applied a single layer suture technique with the preservation of the pseudocapsule-for all cesarean myomectomy cases
Exclusion Criteria
* Patients with coagulation disorders
* Patients with a history of previous intraabdominal surgery on reproductive organs
* Patients with a history of endometriosis
18 Years
49 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bilge Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Oguz Guler
Principle investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oguz Guler, M.D.
Role: PRINCIPAL_INVESTIGATOR
Bilge Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medicana Samsun Hospital
Samsun, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.